Author

K. D. Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Organism:human· 1

Frequent Co-Authors

C. J. Lee· 2 shared M.-H. Nam· 2 shared B. K. Jang· 1 shared D. Kim· 1 shared D.-W. Cho· 1 shared E. J. Shin· 1 shared H. H. Jo· 1 shared H. H. Yoon· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. J. Lee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Visualizing cancer-originated acetate uptake through MCT1 in reactive astrocytes demarcates tumor border and extends survival in glioblastoma patients

H. Y. Ko, J.-I. Chung, D. Kim, Y. M. Park, H. H. Jo, S. Lee, S. Y. Kim, J. Kim, J.-H. Chun, K.-S. Han, M. Lee, Y. Ju, S. J. Park, K. D. Park, M.-H. Nam, , M. Yun

This study uses AcePET to visualize tumor boundaries and reactive astrocytes in GBM, showing that targeting MCT1 improves survival by enabling complete resection of cancer stem cells.

bioRxiv · Apr 13, 2021 · PreprintCancer Biology

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease

M.-H. Nam, J.-H. Park, H. J. Song, J. W. Choi, S. Kim, B. K. Jang, H. H. Yoon, J. Y. Heo, D.-W. Cho, Y.-S. Yang, S.-C. Han, S. Kim, S.-J. Oh, S. R. Jeon, K. D. Park, C. J. Lee

This paper tests KDS2010, a reversible MAO-B inhibitor, in PD animal models and finds it effective with low toxicity and superior neuroprotection compared to selegiline.

bioRxiv · Jul 6, 2020Pharmacology & Toxicology

Engineered Heterochronic Parabiosis in 3D Microphysiological System for Identification of Muscle Rejuvenating Factors

Y. Lee, J. J. Choi, S. I. Ahn, N. H. Lee, W. M. Han, M. Mohiuddin, E. J. Shin, L. B. Wood, K. D. Park, Y. Kim, Y. C. Jang

This study develops an in vitro muscle parabiosis system to identify rejuvenating factors in aged muscle stem cells by mimicking systemic and local signals.

bioRxiv · Mar 10, 2020Cell Biology